BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6644333)

  • 1. In vitro and in vivo effects of levamisole on monocyte chemotaxis in normal donors and patients with colorectal carcinoma.
    Groveman DS; Borden EC
    J Biol Response Mod; 1983; 2(2):167-74. PubMed ID: 6644333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of orally administered levamisole on random monocyte motility and chemotaxis in man.
    Nathanson SD; Zamfirescu PL; Portaro JK; deKernion JB; Fahey JL
    J Natl Cancer Inst; 1978 Aug; 61(2):301-6. PubMed ID: 355647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte chemotaxis and effect of levamisole in Hodgkin's disease.
    Lukács K; Frendl G; Berényi E; Kávai M; Szabó G; Szegedi G
    Acta Med Acad Sci Hung; 1980; 37(2):145-50. PubMed ID: 7457021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil function in surgical patients: in vitro correlation of abnormal neutrophil chemotaxis by Levamisole.
    Christou NV; Meakins JL
    Surgery; 1979 May; 85(5):543-8. PubMed ID: 432816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation of neutrophil chemotaxis in rheumatoid arthritis using levamisole and methisoprinol.
    Mazzone A; Baigura R; Rossini S; Ricevuti G
    Clin Ther; 1986; 8(2):232-7. PubMed ID: 2421905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of levamisole on normal and abnormal leukocyte locomotion.
    Wright DG; Kirkpatrick CH; Gallin JI
    J Clin Invest; 1977 May; 59(5):941-50. PubMed ID: 192765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-mediated suppression of T lymphocyte proliferative response in breast and colorectal cancer patients: specific action of levamisole on suppressor monocytes.
    Han T; Nemoto T; Ledesma EJ; Bruno S; Amery WK
    Int J Immunopharmacol; 1981; 3(1):103-11. PubMed ID: 6457809
    [No Abstract]   [Full Text] [Related]  

  • 8. Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole.
    Rabson AR; Anderson R; Glover A
    Clin Exp Immunol; 1978 Jul; 33(1):142-9. PubMed ID: 709909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased monocyte phagocytosis and decreased lymphocyte mitogen reactivity in colorectal cancer patients.
    Ruco LP; Procopio A; Valtieri M; Uccini S; Chirletti P; Baroni CD
    Appl Pathol; 1983; 1(3):149-56. PubMed ID: 6678592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
    Muhrer KH; Kahle M; Pasurka B
    Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
    Jayappa HG; Loken KI
    Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of various adjuvant drugs used in intensive care on monocyte chemotaxis].
    Krumholz W; Stubbe K; Szalay G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Aug; 37(8):463-7. PubMed ID: 12165915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levamisole as an immunostimulating factor].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1979; 8():56-62. PubMed ID: 318115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of D-pencillamine and levamisole on leucocyte chemotaxis in the rat.
    Cunningham FM; Ford-Hutchinson AW; Oliver AM; Smith MJ; Walker JR
    Br J Pharmacol; 1978 May; 63(1):119-23. PubMed ID: 647156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunochemotherapy for colorectal cancer patients with levamisole].
    Miwa H; Kobayashi T; Ono F; Orita K
    Nihon Gan Chiryo Gakkai Shi; 1982 Jun; 17(4):1009-15. PubMed ID: 6813405
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of piroxicam on neutrophil and monocyte-macrophage function.
    Scheinberg MA; Rueda HO; Matheus PC
    Eur J Rheumatol Inflamm; 1983; 6(1):36-40. PubMed ID: 6861812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune capability of rats with colorectal carcinoma treated by resection with or without 5-fluorouracil or levamisole.
    House AK; Maley MA
    J Surg Oncol; 1984 Nov; 27(3):172-8. PubMed ID: 6333555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of levamisole on chemotaxis of granulocytes from uremic patients.
    Modai D; Weissgarten J; Zolf R; Peller S; Averbukh Z; Kaufman S; Shaked U; Cohen N; Golik A; Tieder M
    Nephron; 1988; 49(3):237-9. PubMed ID: 3398984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of human monocyte chemotactic response by levamisole.
    Pike MC; Snyderman R
    Nature; 1976 May; 261(5556):136-7. PubMed ID: 1272382
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidermoid carcinoma-cell culture supernatant's inhibition of monocyte chemotaxis: evidence for a tumour-mediated effect.
    Güngör A; Yetgin S; Ustacelebi S; Sozeri B
    J Otolaryngol; 1994 Aug; 23(4):229-33. PubMed ID: 7996619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.